Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metronidazole cream to prevent or treat erlotinib-associated rash in patients with non-squamous non-small cell lung cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metronidazole cream (metronidazole)
  • Tarceva (erlotinib) (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-23